MEDICA GROUP PLC

Major Shareholding Notification • May 4, 2023

National Storage Mechanism | Additional information

RNS Number : 3409Y

Medica Group PLC

04 May 2023

FORM 8 (OPD)

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

1.         KEY INFORMATION

(a) Full name of discloser:	Medica Group plc
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):      The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.	N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:      Use a separate form for each offeror/offeree	Medica Group plc
(d) Is the discloser the offeror or the offeree?	OFFEREE
(e) Date position held:      The latest practicable date prior to the disclosure	03 May 2023
(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?      If it is a cash offer or possible cash offer, state "N/A"	N/A

2.         POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

Class of relevant security:
	Interests		Short positions
Number	%	Number	%
(1) Relevant securities owned and/or controlled:	Nil	-	Nil	-
(2) Cash-settled derivatives:	Nil	-	Nil	-
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:	Nil	-	Nil	-
TOTAL:	Nil	-	Nil	-

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

(b)        Rights to subscribe for new securities

Class of relevant security in relation to which subscription right exists:	None
Details, including nature of the rights concerned and relevant percentages:	N/A

3.         POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

(a)  Interests in Medica Group plc's ordinary shares of 0.2 pence each held by the directors of Medica Group plc and their close relatives:

Director	No. of ordinary shares held	Percentage of issued share capital (excluding shares under option)
Gordon Roy Davis	132,726	0.10%
Richard Jones	25,156	0.02%
Stuart Quin (1)	177,480	0.14%
Joanne Easton (2)	37,828	0.03%
Dr Junaid Bajwa	17,241	0.01%

(1)     Stuart Quin's holding of 177,480 ordinary shares are beneficially held by his spouse, Mallika Kaviratne

(2)     Of the 37,828 ordinary shares listed, 1,540 shares are held by Joanne Easton's adult son Max Neal Easton

(b)  Interests in Medica Group plc's ordinary shares of 0.2 pence each held by other persons acting in concert with the offeree:

Name	No. of ordinary shares held	Percentage of issued share capital (excluding shares under option)
Kevin Terrins (3)	1,643,943	1.33%

(3)     Of the 1,643,943 ordinary shares listed, 443,943 are held by Kevin Terrins and 1,200,000 are held by Kevin Terrins' partner, Karen Freeburn

(c)  Interests of the directors of Medica Group plc held as options or awards under the share plans of Medica Group plc by the directors of Medica Group plc:

Director	No. of ordinary shares under option	Name of scheme or plan	Exercise price	Exercise period
Stuart Quin	2,684	Medica Group plc Deferred Bonus Plan	N/A	14/4/22-14/4/30
Stuart Quin	17,641	Medica Group plc Deferred Bonus Plan	N/A	26/5/23-26/5/31
Stuart Quin	87,409	Medica Group plc Deferred Bonus Plan	N/A	31/3/24-07/11/32
Stuart Quin	21,418	Medica Group plc Deferred Bonus Plan	N/A	25/3/25-28/4/33
Stuart Quin	280,211	Medica Group plc 2018 Performance Share Plan	N/A	16/09/22-15/09/29
Stuart Quin	220,677	Medica Group plc 2018 Performance Share Plan	N/A	28/05/24-27/05/31
Stuart Quin	110,337	Medica Group plc 2018 Performance Share Plan	N/A	22/06/24-21/06/31
Stuart Quin	269,257	Medica Group plc 2018 Performance Share Plan	N/A	18/04/25-7/11/32
Stuart Quin	290,594	Medica Group plc 2018 Performance Share Plan	N/A	20/04/26-28/4/33
Stuart Quin	18,000	Medica Group plc All-employee Save As You Earn Plan	£1.00	01/07/23-31/12/23
Richard Jones	5,187	Medica Group plc Deferred Bonus Plan	N/A	26/05/23-26/05/31
Richard Jones	61,700	Medica Group plc Deferred Bonus Plan	N/A	31/03/24-07/11/32
Richard Jones	15,119	Medica Group plc Deferred Bonus Plan	N/A	25/03/25-28/04/33
Richard Jones	458,895	Medica Group plc 2018 Performance Share Plan	N/A	10/11/23-09/11/30
Richard Jones	155,771	Medica Group PLC 2018 Performance Share Plan	N/A	28/05/24-27/05/31
Richard Jones	77,884	Medica Group plc 2018 Performance Share Plan	N/A	22/06/24-21/06/31
Richard Jones	190,064	Medica Group plc 2018 Performance Share Plan	N/A	18/04/25-07/11/32
Richard Jones	205,125	Medica Group plc 2018 Performance Share Plan	N/A	20/04/26-28/04/33
Richard Jones	12,328	Medica Group plc All-employee Save As You Earn Plan	£1.46	01/07/24-31/12/24

(d)  Interests of other persons acting in concert with the offeree held as options or awards under the share plans of Medica Group plc:

Director	No. of ordinary shares under option	Name of scheme or plan	Exercise price	Exercise period
Kevin Terrins	38,181	Medica Group plc Deferred Bonus Plan	N/A	31/03/24-07/11/32
Kevin Terrins	10,546	Medica Group plc Deferred Bonus Plan	N/A	25/03/25-28/04/33
Kevin Terrins	47,993	Medica Group plc 2017 Performance Share Plan	N/A	21/03/22-20/03/27
Kevin Terrins	96,392	Medica Group plc 2018 Performance Share Plan	N/A	28/05/24-27/05/31
Kevin Terrins	48,195	Medica Group plc 2018 Performance Share Plan	N/A	22/06/24-21/06/31
Kevin Terrins	121,212	Medica Group plc 2018 Performance Share Plan	N/A	18/04/25-07/11/32
Kevin Terrins	31,400	Medica Group plc 2018 Performance Share Plan	N/A	25/04/23-07/11/32
Kevin Terrins	143,081	Medica Group plc 2018 Performance Share Plan	N/A	20/04/26-28/04/33
Kevin Terrins	18,000	Medica Group plc All-employee Save As You Earn Plan	£1.00	01/07/23-31/12/23

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

4.         OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"
None

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to: (i)  the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none"
None

(c)        Attachments

Are any Supplemental Forms attached?

Supplemental Form 8 (Open Positions)	NO
Supplemental Form 8 (SBL)	NO

###### Date of disclosure:	4 May 2023
###### Contact name:	Richard Jones
###### Telephone number:	+44 (0)1424 377906

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

FEEVXLFBXELBBBE